References
- van der Linde D , KoningsEE, SlagerMAet al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 58(21) , 2241–2247 (2011).
- Khairy P , Ionescu-IttuR, MackieAS, AbrahamowiczM, PiloteL, MarelliAJ. Changing mortality in congenital heart disease. J. Am. Coll. Cardiol.56(14) , 1149–1157 (2010).
- Zomer AC , VaartjesI, UiterwaalCSet al. Circumstances of death in adult congenital heart disease. Int. J. Cardiol. 154(2) , 168–172 (2012).
- Kantor PF , AndelfingerG, DanceaA, KhairyP. Heart failure in congenital heart disease. Can. J. Cardiol.29(7) , 753–754 (2013).
- Eindhoven JA , van den Bosch AE, Jansen PR, Boersma E, Roos-Hesselink JW. The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review. J. Am. Coll. Cardiol.60(21) , 2140–2149 (2012).
- Dore A , HoudeC, ChanKLet al. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation 112(16) , 2411–2416 (2005).
- Manickaraj AK , MitalS. Personalized medicine in pediatric cardiology: do little changes make a big difference? Curr. Opin. Pediatr.24(5) , 584–591 (2012).
- Khairy P . Defibrillators and cardiac resynchronization therapy in congenital heart disease: evolving indications. Expert Rev. Med. Devices5(3) , 267–271 (2008).
- Kirk R , DipchandAI, EdwardsLBet al. The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report – 2012. J. Heart Lung Transplant. 31(10) , 1065–1072 (2012).
- Christie JD , EdwardsLB, KucheryavayaAYet al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report – 2010. J. Heart Lung Transplant. 29(10) , 1104–1118 (2010).
- Greutmann M , PretreR, FurrerLet al. Heart transplantation in adolescent and adult patients with congenital heart disease: a case–control study. Transplant. Proc. 41(9) , 3821–3826 (2009).
- Mitchell MB , CampbellDN, IvyDet al. Evidence of pulmonary vascular disease after heart transplantation for fontan circulation failure. J. Thorac. Cardiovasc. Surg. 128(5) , 693–702 (2004).
- Preuss C , AndelfingerG. Genetics of heart failure in congenital heart disease. Can. J. Cardiol.29(7) , 803–810 (2013).
- Costa MW , GuoG, WolsteinOet al. Functional characterization of a novel mutation in nkx2–5 associated with congenital heart disease and adult-onset cardiomyopathy. Circ. Cardiovasc. Genet. 6(3) , 238–247 (2013).
- Carey AS , LiangL, EdwardsJet al. The impact of cnvs on outcomes for infants with single ventricle heart defects. Circ. Cardiovasc. Genet. 6(5) , 444–451 (2013).
- Soemedi R , WilsonIJ, BenthamJet al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am. J. Hum. Genet. 91(3) , 489–501 (2012).
- Greenway SC , PereiraAC, LinJCet al. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of fallot. Nat. Genet.41(8) , 931–935 (2009).
- Hitz MP , Lemieux-PerreaultLP, MarshallCet al. Rare copy number variants contribute to congenital left-sided heart disease. PLoS Genet. 8(9) , e1002903 (2012).
- Zaidi S , ChoiM, WakimotoHet al. De novo mutations in histone-modifying genes in congenital heart disease. Nature498(7453) , 220–223 (2013).
- Webber SA , BoyleGJ, GribarSet al. Polymorphisms in cytokine genes do not predict progression to end-stage heart failure in children. Cardiol. Young 12(5) , 461–464 (2002).
- Yuan S , ZaidiS, BruecknerM. Congenital heart disease: emerging themes linking genetics and development. Curr. Opin. Genet. Dev.23(3) , 352–359 (2013).
- Fahed AC , GelbBD, SeidmanJG, SeidmanCE. Genetics of congenital heart disease: the glass half empty. Circ. Res.112(4) , 707–720 (2013).
- Mital S , ChungWK, ColanSDet al. Renin–angiotensin–aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation 123(21) , 2353-2362 (2011).
- Hsu DT , ZakV, MahonyLet al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 122(4) , 333–340 (2010).
- Girnita DM , OhmannEL, BrooksMMet al. Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study. Transplantation 91(12) , 1326–1332 (2011).
- Auerbach SR , ManlhiotC, ReddySet al. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation. J. Am. Coll. Cardiol. 53(20) , 1909–1917 (2009).
- Feingold B , BrooksMM, ZeeviAet al. Renal function and genetic polymorphisms in pediatric heart transplant recipients. J. Heart Lung Transplant. 31(9) , 1003–1008 (2012).
- Filippo SD , ZeeviA, McDadeKKet al. Impact of tgfβ1 gene polymorphisms on late renal function in pediatric heart transplantation. Hum. Immunol. 66(2) , 133–139 (2005).
- Gijsen V , MitalS, van Schaik RH et al. Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. J. Heart Lung Transplant.30(12) , 1352–1359 (2011).
- Zheng H , WebberS, ZeeviAet al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and mdr1 gene polymorphisms. Am. J. Transplant. 3(4) , 477–483 (2003).
- Gijsen V , MitalS, van Schaik RH et al. Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. J. Heart Lung Transplant.30(12) , 1352–1359 (2011).
- Zhao W , FakhouryM, BaudouinVet al. Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients. Eur. J. Clin. Pharmacol. 69(2) , 189–195 (2013).
- Thervet E , LoriotMA, BarbierSet al. Optimization of initial tacrolimus dose using pharmacogenetic testing. Clin. Pharmacol. Ther. 87(6) , 721–726 (2010).